Research Reports

Key takeaways

All six nominated directors elected with majority votes in their respective Class A and Class B common stock classes.

Amended 2017 Incentive Award Plan approved, increasing shares reserved by 335,000 and extending expiration to March 18, 2036.

KPMG LLP ratified as independent auditors for fiscal year ending December 31, 2026 with majority voting power approval.

Advisory vote on executive compensation approved with majority support.

Stockholder proposal on dual class capital structure rejected, receiving only 1,469,297 For votes versus 5,459,554 Against.

Full analysis

The Annual Meeting outcomes reflect strong stockholder support for the Company's board, governance practices, and compensation structure, with all director nominees receiving majority approval in their classes and key proposals like auditor ratification, say-on-pay, and the incentive plan amendment passing comfortably. The amended 2017 Incentive Award Plan's approval adds 335,000 shares to the reserve and extends the term to 2036, enhancing the Company's flexibility to attract and retain talent through equity incentives. Rejection of the dual class proposal indicates limited support for altering the existing capital structure, maintaining continuity in voting rights dynamics.

BIO · Bio-Rad Laboratories, Inc.

Summary

Key takeaways

Full analysis